Cargando…
Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease
Kinases are an intensively studied drug target class in current pharmacological research as evidenced by the large number of kinase inhibitors being assessed in clinical trials. Kinase-targeted therapies have potential for treatment of a broad array of indications including central nervous system (C...
Autores principales: | Benn, Caroline L., Dawson, Lee A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494159/ https://www.ncbi.nlm.nih.gov/pubmed/33117143 http://dx.doi.org/10.3389/fnagi.2020.00242 |
Ejemplares similares
-
The Role of Unfolded Protein Response and Mitogen-Activated Protein Kinase Signaling in Neurodegenerative Diseases with Special Focus on Prion Diseases
por: Shah, Syed Zahid Ali, et al.
Publicado: (2017) -
Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?
por: Lordén, Gema, et al.
Publicado: (2021) -
Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
por: Wells, Cameron, et al.
Publicado: (2019) -
Protein Kinases and Neurodegenerative Diseases
por: Kawahata, Ichiro, et al.
Publicado: (2023) -
The many questions on the use of biomarkers for neurodegenerative diseases in clinical practice
por: Menéndez-González, Manuel
Publicado: (2014)